Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Melatonin on Cardiac Biomarkers in Coronary Artery Bypass Surgery
IRCT20260513069384N1Phase 3Recruiting
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in coronary arteriosclerosis, sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Change in cardiac biomarkers. Started Jul 2026; status: recruiting.
02
Drugs
melatonin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20260513069384N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260513069384N1.